Proficio Capital Partners LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 185,802 shares of the company's stock, valued at approximately $186,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Centricity Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $27,000. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Bernard Wealth Management Corp. acquired a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $36,000. Roxbury Financial LLC bought a new stake in Colgate-Palmolive in the fourth quarter worth approximately $43,000. Finally, BankPlus Trust Department acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth $46,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on the stock. UBS Group decreased their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a report on Monday, February 3rd. Barclays decreased their price target on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research note on Friday, January 17th. Morgan Stanley cut their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. Finally, TD Cowen lowered their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of "Moderate Buy" and a consensus price target of $101.61.
Check Out Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Stock Performance
CL traded down $0.41 on Thursday, hitting $90.41. 4,396,356 shares of the stock traded hands, compared to its average volume of 4,180,981. The business has a fifty day moving average price of $89.03 and a two-hundred day moving average price of $94.96. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The firm has a market capitalization of $73.37 billion, a PE ratio of 25.69, a P/E/G ratio of 4.20 and a beta of 0.40.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the company earned $0.87 earnings per share. On average, research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.